Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy

Jonathan M. Pitt; Aurélien Marabelle; Alexander Eggermont; J.C. Soria; Guido Guido Kroemer; Laurence Zitvogel

doi:10.1093/annonc/mdw168

Related publications

Article2023

Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma

Masahiro Morita, Naoshi Nishida, Tomoko Aoki, Hirokazu Chishina, Masahiro Takita, Hiroshi Ida, Satoru Hagiwara, Yasunori Minami, Kazuomi Ueshima, Masatoshi Kudo

Article2021

Innate immune cells in the tumor microenvironment

Ming O. Li, Natalie K. Wolf, David H Raulet, Leila Akkari, Mikaël J. Pittet, Paulo C. Rodrı́guez, Rosandra N. Kaplan, Ariel Munitz, Zemin Zhang, Sijin Cheng, Nina Bhardwaj

Article2021

Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma

Lisa Haas, Anais Elewaut, Camille L. Gérard, Christian Umkehrer, Lukas Leiendecker, Malin Pedersen, Izabela Kręcioch, David Hoffmann, Maria Novatchkova, Mario Kuttke, Tobias Neumann, Inês Pires da Silva, Harriet Witthock, Michel A. Cuendet, Sebastian Carotta, Kevin J. Harrington, Johannes Zuber, Richard A Scolyer, Georgina V. Long, James S. Wilmott, Olivier Michielin, Sakari Vanharanta,

Article2025

Targeting complex IV to alter the tumor microenvironment and boost macrophage antitumor immunity

T. Joshua Pfefer, Luke O'neill

Article2012

Inflammasomes in carcinogenesis and anticancer immune responses

Laurence Zitvogel, Oliver Kepp, Lorenzo Galluzzi, Guido Guido Kroemer